These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4369990)

  • 41. Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients.
    Merchant RH; Shirodkar A; Ahmed J
    Indian J Pediatr; 2011 Jun; 78(6):679-83. PubMed ID: 21234716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stature and longitudinal growth in thalassemia major. A study of 229 Greek patients.
    Constantoulakis M; Panagopoulos G; Augoustaki O
    Clin Pediatr (Phila); 1975 Apr; 14(4):355-7/362-8. PubMed ID: 164311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-HCV and hemoglobinopathies].
    Mattlinger B; Couroucé AM; Girot R
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):369-73. PubMed ID: 2177601
    [No Abstract]   [Full Text] [Related]  

  • 44. [Auxological and intellectual development of 90 subjects with Cooley's disease].
    Valiani R; Mastrobuoni A; Lafaiette C; Brandonisio A
    Acta Neurol (Napoli); 1981 Feb; 3(1):305-11. PubMed ID: 7246309
    [No Abstract]   [Full Text] [Related]  

  • 45. The management of thalassemia major.
    Pearson HA; O'Brien RT
    Semin Hematol; 1975 Jul; 12(3):255-65. PubMed ID: 1079633
    [No Abstract]   [Full Text] [Related]  

  • 46. [Plasma 17-hydroxycorticosteroids (OHCS) and 17-ketosteroids (KS) (including urinary contents): interpretation of the test results in the field of internal medicine].
    Iwai K; Yawata M; Tamura Y; Sako Y; Honda H
    Nihon Rinsho; 1969 Mar; ():Suppl:906-20. PubMed ID: 4948301
    [No Abstract]   [Full Text] [Related]  

  • 47. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Thalassemia center of Antalya State Hospital: 15 years of experience (1994 to 2008).
    Canatan D
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):24-7. PubMed ID: 23128337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peripheral dysostosis: investigation of metabolic and endocrine functions.
    Garces LY; Blank E; Drash AL; Kenny FM
    J Pediatr; 1969 May; 74(5):730-7. PubMed ID: 4305182
    [No Abstract]   [Full Text] [Related]  

  • 50. Adrenocortical function in depressive states--study of circadian variation in plasma and urinary steroids.
    Lohrenz FN; Fullerton DT; Fahs H; Wenzel FJ
    Int J Neuropsychiatry; 1968 Feb; 4(1):21-5. PubMed ID: 5645816
    [No Abstract]   [Full Text] [Related]  

  • 51. Growth in children with thalassaemia major and effect of two different transfusion regimens.
    Brook CG; Thompson EN; Marshall WC; Whitehouse RH
    Arch Dis Child; 1969 Oct; 44(237):612-6. PubMed ID: 4310196
    [No Abstract]   [Full Text] [Related]  

  • 52. [Analysis of 17-KS and 17-OHCS in gonadal function tests: interpretation of the test results].
    Yoshida T; Kamata S
    Nihon Rinsho; 1969 Mar; ():Suppl:926-33. PubMed ID: 4260412
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H; Oloomi Z
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The metabolic and endocrine response to acute medical stress.
    Nabarro JD
    Proc R Soc Med; 1969 Apr; 62(4):351-5. PubMed ID: 4309466
    [No Abstract]   [Full Text] [Related]  

  • 55. Deferasirox in children with transfusion-dependent thalassemia or sickle cell anemia: A large cohort real-life experience from Turkey (REACH-THEM).
    Antmen B; Karakaş Z; Yeşilipek MA; Küpesiz OA; Şaşmaz İ; Uygun V; Kurtoğlu E; Oktay G; Aydogan G; Akın M; Salcioglu Z; Vergin C; Kazancı EG; Ünal S; Çalışkan Ü; Aral YZ; Türkkan E; Meral Güneş A; Tunç B; Gümrük F; Ayhan AC; Söker M; Koç A; Oymak Y; Ertem M; Timur Ç; Yıldırmak Y; İrken G; Apak H; Biner B; Eren TG; Işık Balcı Y; Koçak Ü; Karasu G; Akkaynak D; Patıroğlu T
    Eur J Haematol; 2019 Feb; 102(2):123-130. PubMed ID: 30300449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Body growth in Cooley's anemia (homozygous beta-thalassemia) with a correlative study as to other aspects of the illness in 138 cases.
    Logothetis J; Loewenson RB; Augoustaki O; Economidou J; Constantoulakis M
    Pediatrics; 1972 Jul; 50(1):92-9. PubMed ID: 5038114
    [No Abstract]   [Full Text] [Related]  

  • 57. Heterozygous thalassemia and pregnancy: a twenty-five year experience.
    Morrison JC; Roe PL; Stahl RL; Whybrew WD; Bucovaz ET; Wiser WL; Kraus AP; Fish SA
    J Reprod Med; 1973 Jul; 11(1):35-9. PubMed ID: 4717612
    [No Abstract]   [Full Text] [Related]  

  • 58. Aplastic and hypoplastic episodes in sickle cell disease and thalassaemia intermedia.
    Brownell AI; McSwiggan DA; Cubitt WD; Anderson MJ
    J Clin Pathol; 1986 Feb; 39(2):121-4. PubMed ID: 3005372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Determination of serum (and urinary) 17-hydroxycorticosteroids and 17-ketosteroids].
    Iwai K; Honda H
    Nihon Rinsho; 1976; 34 suppl():2112-31. PubMed ID: 186650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.